Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My friends are non-medical. Their incompetent management won’t deter me from using. One of the reasons I stayed on so long is the SAB has the likes of Dr Advincula. He is a superstar in the world of minimal invasive gyn surgery. He wouldn’t put his time and energy into something that doesn’t have a high chance of being a game changer.
Yesterday I told friends that I had an order to sell today. Those friends were ones that had purchased the stock on my advice over the years. I held on for 6 years. Lost about 85% of my investment. Had 85k invested and walking away with 12k. As a robotic surgeon I still believe in the product. However the management of this company since my initial investment has been terrible. I will buy back at a later point but have decided to stop the hemorrhage.
I should not have used the word “crucial.” I should have said greatly improved. I did straight stick lsc gyn surgeries prior to DaVinci. DaVinci has made surgery easier and safer for me because of improved visibility, instrument precision, decreased fatigue, etc. Haptic technology would greatly improve tissue dissection. In a pelvis filled with endometriosis (scar tissue), it would be great to have haptics.
Very sorry for the delayed reply. I just saw the message. Haptic feedback is crucial for tissue dissection. To be able to have the feel of tissue during dissection helps prevent injuring vessels and nerves.
I’ve been following this board for 5 years. I think this has to be the BEST post to date. I’m laughing so hard it’s waking up my wife. It’s nice to be able to laugh so hard when there has been many tears over the last 5 years.
There are two uterine manipulator devices that every Gyn surgeon uses for MIS hysterectomies. Cooper Surgical has the Advincula manipulator, in which I’m sure he has made millions from. The other is Conmed VCare device. It would be interesting if Advincula helps develop the robotic device that joins up with Conmed, which is in direct competition Cooper Surgical.
As a surgeon who has been long for 5 years these design changes are HUGE! The footprint has decreased significantly making it very functional in the OR. These tweets were vital for buyers. Reason why TRXC continues to plummet and not sell. As I have always said the surgeons on the Board are worldwide leaders in their field. If they were not a part of this I would have bailed a long time ago. It looks like management is listening to them.
Not the PR everyone was anticipating but Dr Advincula expanded role is huge! He is one of the most respected MIS Gyn surgeons in the World. As a MIS Gyn surgeon, I can tell you Advincula has very high respect in our field. He wouldn’t have stepped into this role unless he believed in SPORT.
EIT- no it was a previous case they had posted. However watching yesterday’s video was more assurance that SPORT will compete. The snake arms are a big difference compared to other current SP that have limited range of motion. Which is demonstrated with the suture tying.
Two working arms vs three is not a huge deal. Davinci only allows for 2 working arms at a time. The third arm is used for another type of instrument to switch over to without having to change out, or another instrument access location, or for retraction. However most surgery cases only require two working arms. Investinfuture recent post explained it very well.
Boom boom- I’m a surgeon that regularly uses a davinci Xi system on my patients. Your use of medical terminology to describe the limitations of SPORT does not make since! “hypogastrium area, anocelia” What the heck are you referring to?
As a gynecologist that uses the Davinci Xi (ISRG) weekly in surgery,
I'm ecstatic that Dr Advincula (Columbia) was mentioned today. He is considered the top if not one of the top leading MIS (minimally invasive surgery) gynecologist in the world. I remember a few years ago when he was announced to the TITXF SAB. I loaded up at around $1.50 PPS. Now today, a few years later, I've loaded up even more. I've been saying for years that TRXC is garbage. There is no way surgeons like, Advincula, would have ever wasted their time on TRXC. I think they see the medical value in Sport and thus are excited about testing it at their facilities.
Not sure if any surgeons have posted since the video came out. I can assure you that Dr Estape's comments are not just because he is getting paid by TITXF. The idea of sitting in a comfortable chair (not peering into a ISRG console monitor) alone is a step up for me. The hysterectomy he did on the pig reminds me of my first hyst on a pig with the DaVinci Si many years ago. There will now be many more surgeons investing in TITXF after watching this video. It's starting to become real!!! Any other ISRG surgeons out there that see other functional benefits of Sport over Xi? I think talking to OR staff will also be easier than how it works with the ISRG console.
As a surgeon I'm boggled that TRXC PPS is increasing. The unit is useless and will never make it into a handful of OR's.
Adrock- I haven't been able to keep up with the board lately. It appears they didn't raise the entire 17mil in the last offering. If not is there another offering needed before design freeze? I've been purchasing after every drop in PPS, thinking it will be the last major drop. I see you are still buying. Is that because you see no further offerings needed prior to design freeze or because you think a buyout is imminent? Thanks for feedback.
It's appearing to be a dark day in TITXF land. I've been long for 3 years and appreciated all the input from members in the past. It seems like in previous years there were always people either at the AGM or listening to a live stream that would post updates. Has anyone heard anything from the meeting?
Only a simple hyst was done on cadaver. Rad hyst is a gyn oncology surgery involving extensive dissection. Rad hysts are performed with the DaVinci. Given the platform, Sport should allow for a gyn/Onc to perform a rad hyst. But initially focus will be on the bread and butter of gyn surgery, simple robotic assisted to total laparoscopic hysterectomy.
Lol. Used Siri between surgery cases to post. Your right grammar isn't taught in medical school or residency. I do know about robotic surgery but I guess that doesn't matter.
As a surgeon this past weekend I watched a posted video of a Sport colon surgery and was salivating at the capabilities of Sport. This piece of equipment is awesome, coming from a guy who does DaVinci surgeries weekly. But this whole financing issue is a complete disaster. If they had anyone that new how to raise money and market, it would be a huge success.
I received an email today from ECV responding that the board is "aggressively exploring" other financing options. My response is they need to find a buyer ASAP and stop trying to go solo. Unless I'm missing something from a surgeons point of view this would seem to be an easy sell to one of the big players in the industry.
Does anyone have the number for the ECV?
Advincula is the current president of AAGL. He is considered one of the leading MIG surgeons in the world. As an Ob/Gyn, when I saw he was on the SAB, that is what sold me on TITXF a few years ago. Unfortunately the admins running this company are not at the same caliber in their profession as Advincula. Also highly unlikely the SSI platform at the conference is Sport. ISRG runs the show at these conferences.
Can someone please post management's email addresses. All I can find on their website is Bertner. Thanks
The plaintiff has as much chance in winning this as TRXC has in making it into 20 OR's in the US.
I'm a Gyn surgeon and use Davinci Xi weekly. I don't see Surgibot making it. They way it functions is very similar to traditional laparoscopic surgery with articulating instruments. I.e. nothing new or progressive. I would love to hear from a surgeon that would prefer the Surgibot setup over Davinci or Sport.
ST thank you for posting all the pics/videos at SAGES. You seem surprised about your center possibly buying the SPORT. It's probably like a dad seeing his son give him his first Christmas present. I'm sure you all have a DaVinci Si/Xi? This is seeming like more and more of a no brainer. I don't see SPORT dominating over the next few years because of the product and the price point.
I'm just scanning through the posts so I'm not sure if Robodoc responded but any clip device can fit through an appropriate accessory port. SPORT will definitely be suitable for robotics.
LTG I have no clue who you are but have been seeing your friendly banter over this forum over the last year. I have kept my mouth shut until the most recent demo at SAGES. Now that I have seen the finised TITXF product I'm certain that it will be the only competitor in the near future with DaVinci. I do robotic surgery weekly. I find it amusing that you contunue to slam TITXF when it clearly will be the competitor to ISRG. I think you like the TRXC products. Please find a surgeon that supports their product. I would love to find out why. If I were you I would ditch TRXC ASAP and invest in a product that will be in the ORs in 10 years.
As another surgeon that is active in robotic surgery I completely agree. I think the VC groups havr to be looking at SPORT now that it's demos are at these conferences. I appreciate the cadaver dissction posted to the TITXF FB site. This is robotic surgery you all. I would love to test drive it but from what I'm seeing it's very similar to DaVinci. Many of you know where more than I about the market but I can tell you as a surgeon, the TITXF product is looking really good right now.
A capital ISRG 2 years ago told me about TITXF. At that time he was concerned about future competition from TITXF. Currently I know many of the reps are concerned about their domination of the market being impacted by SPORT. I know little about stocks but I've been a physician for 15 years and as a gynecologist I use robotics weekly. Currently nothing besides SPORT will be ready to compete with TITXF. Those videos from SAGES show a great product from my standpoint. As hospital admins are always looking for the "cheaper" product for their OR, SPORT will be the easy choice. I don't need to see the Surgibot in person at SAGES to tell you that it will not be in many ORs in the future. It's clear from watching their online videos. As a surgeon robotic surgery is where laparoscopic (most) surgery is going. There is now a clear competitor to TITXF. I'm not worried about the FDA approval. I am a little concerned about ISRG trying to block it's going to market because of some patent violation. Any attorneys out there that think this might be an issue?
I'm an Ob/Gyn
Cost is 175k including their new table. See video
DaVinci single site has been functional for a few years with their old Si model. The problem was that the instruments did not articulate. So in many ways it was like doing traditional laparoscopic surgery through a single incision. For most surgeries the cosmetic and postop pain benefit did not outweigh the functionality difficulties that "straight stick" single site surgery presents. However with the approval of the Xi model single site platform, the surgeon will be able to use most of the instrument multi-articulating function of the multi port platform. This will be out in many of the current DaVinci markets in the next few months. It will be awesome from what I have seen from the rep. I believe that initially most robotic startups will not be able to compare with Davinci. No hospital who already has a DaVinci unit is going to replace it with the SPORT. However those that don't have robotics will definitely be interested in SPORT over DaVinci because of the cost. Also hospitals that currently have a DaVinci units would likely go with SPORT to add to additional ORs.
As a surgeon who uses the Davinci on a weekly basis, I can tell you that robotic surgery is here to stay. Davinci definitely has an amazing product but their units are so expensive. One of the main arguments of using traditional (straight stick) laparoscopy over robotics. My hospital system just purchased the latest version, Xi, and spent 2.5 million. However the price point for the SPORT will make cost per case comparable to traditional laparoscopy. The affordability of the SPORT compared to Davinci, as well as the design and function compared to TRXC products, it's going to be a winner. I was considering to buy TRXC a while back then I went to their website and viewed their devices. It's been mentioned in many posts in the past, but their products are not going to be placed in OR's throughout this country. They suck. It has been discussed on this forum many times in the past about the inadequate job the TITXF management has done with public relations. They have made some terrible decisions in the past, but their medical advisory board is loaded with some of the best laparoscopic/robotic surgeons in the U.S. They are leaders in their field and national speakers for minimally invasive surgery. These docs wouldn't be backing this product if the product sucked. They see the potential, as I do.